前列腺癌中的性激素结合球蛋白
Sex hormone binding globulin in carcinoma of the prostate.
作者信息
Houghton A L, Turner R, Cooper E H
出版信息
Br J Urol. 1977 Jun;49(3):227-32. doi: 10.1111/j.1464-410x.1977.tb04109.x.
Abstract
Sex Hormone Binding Globulin (SHBG) was measured in 130 patients with carcinoma of the prostate. Its level is raised in patients treated with oestrogen and it is possible that this may be of prognostic significance. The possible relevance of SHBG in oestrogen-treated patients is discussed.
摘要
对130例前列腺癌患者测定了性激素结合球蛋白（SHBG）。接受雌激素治疗的患者其水平升高，这可能具有预后意义。本文讨论了SHBG在接受雌激素治疗患者中的可能相关性。
相似文献
1
Sex hormone binding globulin in carcinoma of the prostate.前列腺癌中的性激素结合球蛋白
Br J Urol. 1977 Jun;49(3):227-32. doi: 10.1111/j.1464-410x.1977.tb04109.x.
2
Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.己烯雌酚和磷酸雌莫司汀对前列腺癌患者血清性激素结合球蛋白及睾酮水平的影响
J Urol. 1980 Aug;124(2):232-6. doi: 10.1016/s0022-5347(17)55383-5.
3
[Plasma testosterone and sex hormone transport globulin in patients with prostatic carcinoma under treatment].[接受治疗的前列腺癌患者的血浆睾酮和性激素转运球蛋白]
Actas Urol Esp. 1982 Jan-Feb;6(1):17-20.
4
Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
Acta Endocrinol (Copenh). 1977 Jul;85(3):650-64. doi: 10.1530/acta.0.0850650.
5
Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients.前列腺癌患者治疗前睾酮血浆水平及性激素结合球蛋白结合能力与临床分期和生存率的关系
Prostate. 1988;12(4):325-32. doi: 10.1002/pros.2990120406.
6
Relationship of testosterone, sex hormone binding globulin, and calculated free testosterone to subsequent clinical progress in patients with carcinoma of the prostate treated with bilateral orchidectomy or estrogens.睾酮、性激素结合球蛋白及计算得出的游离睾酮与接受双侧睾丸切除术或雌激素治疗的前列腺癌患者后续临床进展的关系。
Prostate. 1987;11(1):17-21. doi: 10.1002/pros.2990110103.
7
Plasma sex hormone binding globulin in patients with prostatic carcinoma.前列腺癌患者的血浆性激素结合球蛋白
Cancer. 1990 Jul 15;66(2):354-7. doi: 10.1002/1097-0142(19900715)66:2<354::aid-cncr2820660225>3.0.co;2-n.
8
9
[Endocrine findings during hormonal treatment of metastasizing prostatic carcinoma].[转移性前列腺癌激素治疗期间的内分泌学发现]
Urol Int. 1982;37(6):400-9. doi: 10.1159/000280846.
10
Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy.前列腺癌：血浆促黄体生成素和睾酮对雌激素治疗的反应。
Br Med J. 1968 Jan 6;1(5583):28-30. doi: 10.1136/bmj.1.5583.28.
引用本文的文献
1
The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma.
Urol Res. 1982;10(3):119-22. doi: 10.1007/BF00255953.
Zotero 插件